Advanced Ocular Systems Offered: Auslndustry Commercial Ready Grant

摘要

Advanced Ocular Systems Ltd announced that it has been offered an Auslndustry Commercial Ready grant that will inject A1 408 457 (US 1 million dollar) of non-dilutive funds into the company over three years to match company funding. The funding will support the development of compounds for the treatment of exudative eye diseases such as conjunctivitis, corneal swelling and retinal diseases. Exudation associated with inflammation can be responsible for loss of vision. Some of the anti-inflammatory compounds in the project are currently in clinical use for other medical conditions, enabling the path to market to be substantially reduced. This work will add to the company's strengthening intellectual property portfolio in ophthalmic diseases and it should enhance the ability to attract a major industry partner to the project.